Gross Profit On Sales Cambiamento Data
Adma Biologics USD 63.33M 3.67M 2024-12
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Dynavax Technologies USD 54.4M 4.23M 2025-03
Takeda JPY 722.01B 50.69B 2025-06


Adma Biologics Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.